Valuation Sanofi Börse Stuttgart

Stocks

Delayed Börse Stuttgart Other stock markets 02:04:09 2026-07-09 EDT			5-day change	1st Jan Change
37.40 ^EUR	0.00%		+2.75%	-8.33%

07-08	European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites	MT
07-08	Sanofi to Address Competition Concerns Over Communication Campaign, European Commission Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	90,461	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-10.13%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	100,159	96,058	92,579
Change	-	-1.71%	1.04%	4.49%	-11.2%	-10.3%	-4.09%	-3.62%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	11.4x	10.4x	8.86x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.2x	1.14x	1.08x
PEG	-	2.07x	-1.1x	3.14x	0.3x	3.23x	1.18x	0.5x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.92x	1.8x	1.71x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.12x	1.91x	1.75x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.85x	6.16x	5.41x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.8x	6.99x	6.15x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	11.7x	10.5x	9.03x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.58%	9.51%	11.1%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.254	4.506	4.831
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.64%	5.98%	6.41%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.626	7.213	8.502
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	64.2%	62.5%	56.8%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,187	50,256	52,891
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,630	15,606	17,098
EBIT ¹	10,714	13,040	12,670	11,343	12,149	12,836	13,744	15,061
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,992	8,901	10,562
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	9,698	5,597	2,119
Reference price ²	88.58	89.84	89.76	93.74	82.72	75.37	75.37	75.37
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,200,220	-	-
Announcement Date	2/4/22	2/3/23	2/1/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,084B
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	634B
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	447B
ROCHE HOLDING AG	17.81x	4.43x	10.97x	2.99%	330B
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	295B
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	285B
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	218B
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	199B
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	169B
Average	16.38x	6.59x	16.89x	2.39%	406.65B
Weighted average by Cap.	24.24x	8.02x	18.60x	1.95%